Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Macy's Inc (M) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade
Macy's IncTrade

Price performance (Past 24H)

Key statistics

Ionis Pharmaceuticals Inc. Common Stock vs Macy's Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Macy's Inc trades at $22.62 (market cap $5.94B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Macy's Inc pays a 3.37% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Macy's Inc for 58 Days on average.

IONSM
Market Cap
$7.04B$5.94B
Volume
2,977,4404,634,768
Sector
HealthConsumer Cyclical
52-Week High
$86.50$26.21
52-Week Low
$42.38$16.92
Typical Hold Time
0 Days58 Days
Enterprise Value
$6.60B$9.73B
Dividend Yield
—3.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Macy's Inc

Macy's (M) trades at $22.68, down 1.35% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company shows improving fundamentals with Q2 2026 earnings beating estimates and raised full-year guidance, supported by a 'Bold New Chapter' strategy driving digital and omnichannel growth. Valuation ratios remain attractive with a P/E of 8.33 and P/S of 0.27, while cash flow trends have strengthened with net cash flow turning positive in 2025.

The outlook is cautiously optimistic given low valuations and strategic initiatives, but risks include competitive pressures, uneven second-half growth expectations, and macroeconomic sensitivity. Analyst consensus is mixed with a $24.25 price target, implying modest upside, though the stock's 3.5% dividend yield adds income appeal for patient investors amid execution risks.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONS
100% Buy0% Sell
Avg holding period · 0 Days
M
0% Buy100% Sell
Avg holding period · 58 Days

Top news

Latest headlines on both assets

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →

About Macy's Inc

Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.

Read more on M →